Skip to main content
Home
Latest news
Browse topics
Lupus Rheumatoid arthritis Spondyloarthropathies COVID-19 Browse all topics
In focus
Bimekizumab: Dual IL-17A/IL-17F inhibition in SpA Anifrolumab for the treatment of SLE JAK inhibitor safety: Weighing up the data and understanding the risks Rituximab and rheumatology practice in the COVID-19 era Safety snapshot: Upadacitinib in patients with PsA Repurposing rheumatology drugs for COVID-19 Telemedicine in rheumatology: COVID-19 and beyond Managing PsA in resource-limited settings
Conferences
ACR Convergence 2022 EULAR 2022 Congress
About us
Medicine Matters Rheumatology
EXTENDED SEARCH

Ankylosing spondylitis

Pathophysiology

03-10-2018 | Ankylosing spondylitis | Article

Influence of HLA-B27 on the ankylosing spondylitis phenotype: Results from the REGISPONSER database

Arévalo M et al. Arthritis Res Ther 2018; 20: 221. doi: 10.1186/s13075-018-1724-7

30-05-2018 | Enthesitis | Review | Article

Enthesitis: Much more than focal insertion point inflammation

Watad A et al. Curr Rheumatol Rep 2018; 20: 41. doi: 10.1007/s11926-018-0751-3

11-05-2018 | Axial spondyloarthritis | Review | Article

Axial disease in psoriatic arthritis and ankylosing spondylitis: A critical comparison

Feld J et al. Nat Rev Rheumatol 2018; 14: 363–371. doi: 10.1038/s41584-018-0006-8

16-04-2018 | Ankylosing spondylitis | Article

Functional defects of Treg cells: New targets in rheumatic diseases, including ankylosing spondylitis

Miao J & Zhu P. Curr Rheumatol Rep 2018; 20(5): 30. doi: 10.1007/s11926-018-0729-1

Read more

Epidemiology

09-08-2018 | Physical activity | Article

The prevalence of co-morbidities and their impact on physical activity in people with inflammatory rheumatic diseases compared with the general population: Results from the UK Biobank

Cook MJ et al. Rheumatology (Oxford) 2018: key224. doi: 10.1093/rheumatology/key224

27-07-2018 | Axial spondyloarthritis | Article

Widespread pain in axial spondyloarthritis: Clinical importance and gender differences

Swinnen TW et al. Arthritis Res Ther 2018; 20: 156. doi: 10.1186/s13075-018-1626-8

20-07-2018 | Fibromyalgia | Article

Influence of comorbid fibromyalgia on disease activity measures and response to tumour necrosis factor inhibitors in axial spondyloarthritis: Results from a UK national register

Macfarlane GJ et al. Rheumatology (Oxford) 2018: key206. doi: 10.1093/rheumatology/key206

11-07-2018 | Axial spondyloarthritis | Article

The prevalence of depression in axial spondyloarthritis and its association with disease activity: A systematic review and meta-analysis

Zhao S et al. Arthritis Res Ther 2018; 20: 140. doi: 10.1186/s13075-018-1644-6

Read more

Diagnosis and screening

25-09-2018 | Ankylosing spondylitis | Article

The effect of extra-articular manifestations on tumor necrosis factor-alpha inhibitor treatment duration in patients with ankylosing spondylitis: Nationwide data from the Korean College of Rheumatology BIOlogics (KOBIO) registry

Kim Y, Park S, Kim HS. Clin Rheumatol 2018. doi: 10.1007/s10067-018-4290-0

20-09-2018 | Devices and technology | Article

Detection of flares by decrease in physical activity, collected using wearable activity trackers, in rheumatoid arthritis or axial spondyloarthritis: An application of machine-learning analyses in rheumatology

Gossec L et al. Arthritis Care Res (Hoboken) 2018. doi: 10.1002/acr.23768

21-08-2018 | Axial spondyloarthritis | Review | Article

Radiologic approach to axial spondyloarthritis: Where are we now and where are we heading?

Kucybała I, Urbanik A, Wojciechowski W. Rheumatol Int 2018. doi: 10.1007/s00296-018-4130-1

11-08-2018 | Spondyloarthropathies | Review | Article

Ultrasound of sacroiliac joints in spondyloarthritis: A systematic review

Gutierrez M et al. Rheumatol Int 2018. doi: 10.1007/s00296-018-4126-x

Read more

Treatment

20-10-2018 | Axial spondyloarthritis | Article

Efficacy and safety of ixekizumab in the treatment of radiographic axial spondyloarthritis: 16 week results of a phase 3 randomized, double‐blind, placebo controlled trial in patients with prior inadequate response or intolerance to tumor necrosis factor inhibitors

Deodhar A et al. Arthritis Rheumatol 2018. doi: 10.1002/art.40753

20-09-2018 | Devices and technology | Article

Detection of flares by decrease in physical activity, collected using wearable activity trackers, in rheumatoid arthritis or axial spondyloarthritis: An application of machine-learning analyses in rheumatology

Gossec L et al. Arthritis Care Res (Hoboken) 2018. doi: 10.1002/acr.23768

01-09-2018 | DMARDs | Review | Article

A practical approach to the use of conventional synthetic, biologic, and targeted synthetic disease modifying anti-rheumatic drugs for the treatment of inflammatory arthritis in patients with a history of malignancy

Wong PKK et al. Curr Rheumatol Rep 2018; 20: 64. doi: 10.1007/s11926-018-0774-9

21-08-2018 | DMARDs | Article

The British Society for Rheumatology biologic DMARD safety guidelines in inflammatory arthritis: Executive summary

Holroyd CR et al. Rheumatology (Oxford) 2018: key207. doi: 10.1093/rheumatology/key207

Read more
Image Credits